SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | +17.7% | 32,465 | +57.0% | 0.00% | 0.0% |
| Q1 2023 | $96 | -37.7% | 20,678 | +8.8% | 0.00% | -50.0% |
| Q4 2022 | $154 | -99.9% | 19,009 | -11.8% | 0.00% | +100.0% |
| Q3 2022 | $120,000 | +12.1% | 21,543 | +4.9% | 0.00% | 0.0% |
| Q2 2022 | $107,000 | -42.2% | 20,533 | +65.0% | 0.00% | 0.0% |
| Q4 2021 | $185,000 | -66.4% | 12,446 | -57.3% | 0.00% | -66.7% |
| Q3 2021 | $551,000 | +253.2% | 29,162 | +326.3% | 0.00% | +200.0% |
| Q1 2021 | $156,000 | +69.6% | 6,841 | -32.6% | 0.00% | 0.0% |
| Q3 2019 | $92,000 | -57.0% | 10,148 | -46.0% | 0.00% | 0.0% |
| Q2 2019 | $214,000 | -28.7% | 18,808 | -28.7% | 0.00% | -66.7% |
| Q1 2019 | $300,000 | +77.5% | 26,380 | +40.6% | 0.00% | +200.0% |
| Q4 2018 | $169,000 | – | 18,761 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |